文章摘要
重复经颅磁刺激联合盐酸替扎尼定治疗脑卒中后上肢屈肌痉挛的效果观察
Effect of repetitive transcranial magnetic stimulation combined with tizanidine hydrochloride in the treatment of upper limb flexor spasm after stroke
投稿时间:2024-11-05  修订日期:2024-11-05
DOI:
中文关键词: 脑卒中  肌痉挛  重复经颅磁刺激  盐酸替扎尼定
英文关键词: Stroke  muscle spasm  repetitive transcranial magnetic stimulation  tezanidine hydrochloride
基金项目:
作者单位邮编
田沛* 中国康复研究中心(北京博爱医院) 100068
于一 中国康复研究中心(北京博爱医院) 
范荣富 中国康复研究中心(北京博爱医院) 
摘要点击次数: 298
全文下载次数: 0
中文摘要:
      目的:探讨低频重复经颅磁刺激(rTMS)与盐酸替扎尼定联合疗法在改善脑卒中患者上肢屈肌痉挛症状中的临床有效性。 方法:收集 2020 年 12 月至 2023 年 12 月入住北京博爱医院接受康复治疗的60例脑卒中后伴上肢屈肌痉挛患者的临床资料,按照治疗方法不同将其分为对照组和观察组各30例,对照组采用口服盐酸替扎尼定治疗,观察组采用盐酸替扎尼定联合低频 rTMS 治疗,两组患者均接受脑卒中二级预防治疗和常规康复训练。在治疗开始前和第 4 周末,采用以下三种评估工具对患者进行全面评价:利用改良 Ashworth 痉挛量表(MAS)测量上肢肘部屈肌的痉挛程度,运用上肢 Fugl-Meyer 运动量表(UFMA)衡量上肢运动功能的恢复程度,并应用改良 Barthel 指数(MBI)来量化患者的日常生活活动能力(ADL)水平。同时记录两组患者不良反应的发生情况。 结果:在治疗开始前,两组患者的MAS、UFMA 及 MBI 评分相近,无统计学上的显著差异(P>0.05)。在接受治疗的第 4 周末,两组患者的以上三项评分较治疗前均得到显著改善,观察组在 UFMA 和 MBI 评分的升高以及 MAS 评分的降低上均明显优于对照组,且差异均有统计学意义(P<0.05)。两组患者不良反应的发生较少且轻微,发生率均为6.67%,主要表现为嗜睡和头晕等。 结论:低频 rTMS 联合盐酸替扎尼定治疗脑卒中后上肢屈肌痉挛相比单用盐酸替扎尼定可有效降低患者偏瘫侧上肢屈肌肌张力,改善患者上肢运动功能,提高患者生活质量,且安全性较好。
英文摘要:
      Objective: To investigate the clinical effect of low-frequency repeated transcranial magnetic stimulation(rTMS)combined with tizanidine hydrochloride in treating patients with the upper limb flexor spasm after stroke. Method: A total of 60 patients with upper limb flexor spasm after stroke who were admitted to the Beijing Bo'ai Hospital for rehabilitation treatment from December 2020 to December 2023 were retrospectively analyzed and divided into the observation group and control group according to different treatment methods, featuring 30 patients per group. The observation group underwent a combined therapy of tizanidine hydrochloride and low-frequency rTMS, whereas the control group solely received tizanidine hydrochloride. Before the start of treatment and at the end of the fourth week, a comprehensive evaluation of the patient will be conducted using the following three assessment tools. The modified Ashworth Spasm Scale (MAS) was utilized for assessing the degree of spasticity in the flexor muscles of the upper extremity, the upper limb Fugl-Meyer assessment(UFMA) was employed to assess motor function and performance of the upper limb, and the modified Barthel Index (MBI) was served as a metric to quantify the patient's functionality in their activities of daily living (ADL). The occurrence of adverse reactions was recorded in both groups. Result: Before the start of treatment, the MAS, UFMA, and MBI scores of the two groups of patients were similar, with no statistically significant difference (P>0.05). At the end of the fourth week of treatment, both groups of patients demonstrated notable progress in the previously mentioned three assessment metrics compared to their pre-treatment levels. The observation group showed significant improvements in UFMA and MBI scores, as well as a decrease in MAS scores, compared to the control group, and the variations observed were statistically meaningful (P<0.05). The occurrence of adverse reactions in the two groups was less and mild, mainly including drowsiness and dizziness. The incidence of adverse reactions was equivalent between the two groups, with no significant difference observed (6.67% in both groups). Conclusion: The combination of low-frequency rTMS and tizanidine hydrochloride is more effective than tizanidine hydrochloride alone in the treatment of upper limb flexor spasm after stroke, which can relieve hemiplegic upper limb spasm, improve the upper limb motor function and improve the quality of life. At the same time, the safety of both is good.
View Fulltext   查看/发表评论  下载PDF阅读器
关闭